Georgetown University Conference Addresses “Invented Diseases & Overtreatment”

2
1497

From CounterPunch: “When a loved one dies is your grief a ‘psychiatric condition’ requiring medication? Why is a vial of insulin, once produced for five dollars, now $300? Is the Alzheimer’s amyloid model accurate in light of weak correlations to actual improved cognition—and new treatments so expensive they threaten to raise Medicare premiums? And finally, does early cancer detection have concerning drawbacks?

These volatile questions characterized the 9th conference of PharmedOut, a Georgetown University Medical Center project, held in June.

Created by a two-year grant from Pfizer’s 2004 off-label neurontin settlement—its Warner-Lambert unit pleaded guilty to off-label marketing—PharmedOut’s focus is to educate healthcare professionals about pharmaceutical marketing practices.”

Article →

***

Back to Around the Web

2 COMMENTS

  1. “PharmedOut’s focus is to educate healthcare professionals about pharmaceutical marketing practices.”

    A much needed focus and job, according to an ethical marketing major, who was fraudulently taught that false advertising is illegal in college. Who is living in an insane world, where almost all big Pharma advertising is based upon scientific fraud, thus technically illegal.

    Report comment

  2. If there was such a thing as ethical marketing the next psych drug pushed out by big pharma would be called “Triffid” and sincerely marketed as a hero plant based medicine that modestly recovered you from your darkest fear.

    Report comment

LEAVE A REPLY